ApoAI mimetic peptide D4F (with 4 phenylalanine residues) synthesized with D-amino acids has been demonstrated to reduce atherosclerosis in apolipoprotein E (apoE)-null and LDL-receptor-null mice [10, 11]. This evidence concerns the gene APOE and atherosclerosis.